S&H Pharma SRL
2.3 FTES&H Pharma reported total assets of 764,938 € at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Aug 2026), with 2.3 full-time equivalents.
The score of S&H Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +19 % Total assets +8 % Headcount (avg FTE) +53 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
S&H Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 55,644 € | ||||
| Equity | 320,239 € | ||||
| Cash | 28,101 € | ||||
| EBITDA | 99,203 € | ||||
| Total assets | 764,938 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Aug 2026
- Year ended 31 Dec 2024filed on 21 Aug 2025
- Year ended 31 Dec 2023filed on 07 Aug 2024
- Year ended 31 Dec 2022filed on 10 Aug 2023
- Year ended 31 Dec 2021filed on 16 Aug 2022
S&H Pharma's financial analysis
- Solvency41.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of S&H Pharma
S&H Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0835.699.342
- VAT number
- BE0835699342
- Peppol
- Registered · 0208:0835699342 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 19 Apr 2011
- Registered office
- 9051 Ghent
- Size
- Micro · 2.3 FTE
- Latest accounts
- 2025 · filed on 06 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
S&H Pharma (SRL) has been based in Ghent since 2011, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 55,644 € and equity of 320,239 €; its revenue is not published. With 2.3 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 41.9%, below the median of its sector (44.2%).
Companies similar to S&H Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Just Pharma Retail sale of pharmaceutical products Aalst · balance sheet 765,008 €
- Beirnaert-Delagaye Retail sale of pharmaceutical products Ghent · balance sheet 766,047 €
- Kabbeek Farma Retail sale of pharmaceutical products Tienen · balance sheet 763,791 €
- Pharmacie Ghisbain Retail sale of pharmaceutical products Seraing · balance sheet 762,816 €
- Mariec.C-Pharma Retail sale of pharmaceutical products Seneffe · balance sheet 759,407 €
- Pharmacies GOFFIN Retail sale of pharmaceutical products Liège · balance sheet 771,286 €
- Frapeja Pharma Retail sale of pharmaceutical products Ghent · balance sheet 772,946 €
- Brehophar Retail sale of pharmaceutical products Oostkamp · balance sheet 775,082 €
Frequently asked questions about S&H Pharma
What is the revenue of S&H Pharma?
S&H Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of S&H Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0835699342 for S&H Pharma, if the company is VAT-registered. Its company number (CBE) is 0835.699.342.
Where is the registered office of S&H Pharma?
According to the CBE register, the registered office of S&H Pharma is in 9051 Ghent.
What is the equity of S&H Pharma?
At the close of the 2025 financial year, the equity of S&H Pharma amounts to 320,239 €, a solvency of 41.9% of total assets.
How many people work at S&H Pharma?
2.3 full-time equivalents on average according to the 2025 social balance sheet.
Who manages S&H Pharma?
The register lists 2 active mandates at S&H Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of S&H Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →